from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1248c/-

LFCtreatmentdescriptionclass of inhibitor

-1.758

Amikacinug/mL Amikacintranslation

-2.621

Cap5-10ug/mL Capreomycintranslation

-3.069

Rox10-50 ug/mL Roxithromycintranslation

0.340

SM2-5 ug/mL Streptomycintranslation

-1.573

Tet5-10 ug/mL Tetracyclinetranslation

-0.750

Rif0.2-5ug/mL Rifampicintranscription

-0.088

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.159

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.541

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.441

CPZ10-50 ug/mL Chlorpromazinerespiration

0.730

Clofazimine10-13 ug/mL Clofaziminerespiration

0.686

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.188

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.471

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.065

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.898

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.947

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.917

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.439

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.394

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.486

KCN5-20 ug/mL Potassium cyaniderespiration

0.338

NaN30.2-2 mM Sodium aziderespiration

1.643

Nigericin50 uM Nigericinrespiration

0.192

TRC10-150 ug/mL Triclosanrespiration

0.272

TRZ10-25 ug/mL Thioridazinerespiration

-1.676

Valinomycin0.5-10 uM Valinomycinrespiration

0.515

ZnSO42 mM ZnSO4respiration

0.407

menadione6-10 ug/mL Menadionerespiration

0.397

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.191

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.364

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.251

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.143

NRP_1Non-replicating persistence stage 1dosRassociated

0.151

Amp0.2mg/mL AmpicillincellWall

0.109

Cephalexin20-100 ug/mL CephalexincellWall

-0.137

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.058

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.188

EMB10-20 ug/mL EthambutolcellWall

-0.048

Eta12-40 ug/mL EthionamidecellWall

-0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

0.004

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.446

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.338

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.465

BZA0.12 mg/mL BenzamidearomaticAmides

0.045

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.436

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.725

H2O24 mM hydrogen peroxideDNAdamaging

-0.312

Levo10 ug/mL LevofloxacinDNAdamaging

0.076

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.250

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.048

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.060

UVUV-irradiationDNAdamaging

-0.927

ARP41-4 ug/mL Antitubercular compound ARP4?

0.047

Antimycin12.5-50 ug/mL Antimycin A?

0.013

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.487

PA_110-50 ug/mL Antitubercular compound PA-1?

0.517

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.386

PA8240.2-2 ug/mL PA-824?

-0.465

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.340

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.665

Verapamil50 uM Verapamil?

0.411

mercaptoethanol2 mM 2-Mercaptoethanol?

0.547

methoxatin10-20 ug/mL Methoxatin?